Portal de Periódicos da CAPES

THE MANAGEMENT OF HAEMORRHAGE IN THE REFRACTORY NON‐ALLOIMMUNIZED THROMBOCYTOPENIC PATIENT

1994; Wiley; Volume: 67; Issue: s3 Linguagem: Inglês

10.1111/j.1423-0410.1994.tb04553.x

1423-0410

William G. Murphy, Jerry P. Palmer, R.H.A. GREEN,

Blood transfusion and management

Vox SanguinisVolume 67, Issue s3 p. 99-103 THE MANAGEMENT OF HAEMORRHAGE IN THE REFRACTORY NON-ALLOIMMUNIZED THROMBOCYTOPENIC PATIENT W.G. MURPHY, W.G. MURPHY South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this authorJ.P. PALMER, J.P. PALMER South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this authorR.H.A. GREEN, R.H.A. GREEN South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this author W.G. MURPHY, W.G. MURPHY South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this authorJ.P. PALMER, J.P. PALMER South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this authorR.H.A. GREEN, R.H.A. GREEN South East Scotland Blood Transfusion Service Academic Unit 2 Forrest Road Edinburgh EH1 2QNSearch for more papers by this author First published: July 1994 https://doi.org/10.1111/j.1423-0410.1994.tb04553.xCitations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gmur, J, Berger, J, Schanz, U et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338: 1223–1226. 2 Gaydos, LA, Freireich, EJ, Mantel, N. The quantitative relation between platelet count and haemorrhage in patients with acute leukaemia. N Engl J Med 1962; 266: 905–909. 3 Heddle, N. A critical appraisal of clinical studies investigating the efficacy of leukodepletion to improve platelet transfusion response. Proceedings of the Royal College of Physicians of Edinburgh. In Press. 4 Bishop, JF, McGrath, K, Wolf, MM et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988; 71: 383–387. 5 Parker, RD, Yamamoto, LA, Miller, WR. Interaction effects analysis of platelet transfusion data. Transfusion 1974; 14: 567–73. 6 McFarland, JG, Anderson, AJ, Slichter, SJ. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Brit J Haematol 1989; 73: 380–6. 7 Murphy, MF, Waters, AH. Clinical aspects of platelet transfusions. Blood Coagulation and Fibrinolysis 1991; 2: 389–396. 8 NIH Consensus conference: Platelet transfusion therapy. JAMA 1987; 257: 1777–1780. 9 British Committee for Standards in Haematology. Guidelines for platelet transfusions. Transfusion Medicine 1992; 2: 311–318. 10 Slichter, SJ. Mechanisms and management of platelet refractoriness. In: S J Nance, ed, Transfusion Medicine in the 1990′s, American Association of Blood Banks, Arlington, VA 1990: 95–179. 11 Bartholomew, JR, Salgia, R, Bell, WR. Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid. Arch Intern Med 1989; 149: 1959. 12 Garewal, HS, Durie, BGM. Anti-fibrinolytic therapy in aminocaproic acid for the control of bleeding in thrombocytopenic patients. Scand J Haematol 1985; 35: 497. 13 Gardner, FH, Helmer, RE. Aminocaproic acid. Use in control of haemorrhage in patients with amegakaryocytic thrombocytopenia. JAMA 1980; 243: 35. 14 Roath, OS, Majer, RV, Smith, AG. The use of aprotinin in thrombocytopenic patients: a preliminary evaluation. Blood Coagulation and Fibrinolysis 1990; 1: 235–239. 15 Schmitt, H. Indications and clinical effect of fibrinogen preparations. Vox Sang 1969; 16: 442–447. 16 Escolar, G, Garrido, M, Massara, R et al. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 1988; 28: 406–411. 17 Lim, S, Broughton, BJ, Bareford, D. Thrombocytopenia following routine blood transfusion: Microaggregate blood filters prevent worsening thrombocytopenia in patients with low platelet counts. Vox Sang 1989; 56: 40–41. 18 Green, RHA, Palmer, JB, Parker, AC, Mackie, MJ, Murphy, WG. The clinical efficacy of platelet transfusions: a prospective study. International Society of Blood Transfusion Meeting 1994: Abstract 435. 19 Bessos, H, Seghatchian, MJ, Cutts, M et al. Glycoproteins lb and llb/IIIa in the quality assessment of platelet concentrates during storage. Blood Coagulation and Fibrinolysis 1992; 3: 633–636. 20 Bessos, H and Murphy, WG. A new competitive binding enzyme-linked immunosorbent assay for glycocalicin in plasma and platelet concentrate supernatants. Thrombosis Research 1990; 59: 497–507. 21 Janson, PA, Jubelirer, SJ, Weinstein, MJ et al. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 1980; 303: 1318. 22 Gerritsen, SW, Akkerman, J-WN, Sixma, JJ. Correction of the bleeding time in patients with storage pool deficiency by infusion of cryoprecipitate. Brit J Haematol 1978; 40: 153. 23 International patent application number PCT/US92/09396. Reconstituted platelet membrane vesicles. International publication number WO 1993/08812, World Intellectual Property Organization 1993. 24 George, JN, Pickett, EB, Heinz, R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68: 307–309. 25 Kram, HB, Nathan, RC, Stafford, FJ et al. Fibrin glue achieves hemostasis in patients with coagulation disorders. Arch Surg 1989; 124: 385–387. 26 Baudo, F, De Cataldo, F, Landonio, G et al. Management of oral bleeding in haemophiliac patients. Lancet 1988; 2: 1082. Citing Literature Volume67, Issues3July 1994Pages 99-103 ReferencesRelatedInformation